Health stocks: pent up demand returning in time
Nedbank Private Wealth’s Preston Narainsamy on Life Healthcare’s Alzheimer’s drug and Q1 GDP figures. Sygnia CEO David Hufton unpacks results as passive investing continues to grow. Omri Thomas, director of Abax Investments, talks mandate drift and equities for income.
COMMENTS 0
You must be signed in to comment.
SIGN IN SIGN UP